Skip to content

The effect of different doses of dexmedetomidine on anesthesia depth monitoring in children

The effect of different doses of dexmedetomidine on anesthesia depth monitoring of sevoflurane in children

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026872
Enrollment
Unknown
Registered
2019-10-24
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concealed penis and hypospadias

Interventions

Group C:No use of dexmedetomidine
Group D1:IV 0.25 µ g / kg dexmedetomidine
Group D2:IV 0.5 µ g / kg dexmedetomidine
Group D3:IV 0.75 µ g / kg dexmedetomidine

Sponsors

Hunan Children's Hosptal
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 12 Years

Inclusion criteria

Inclusion criteria: A total of 120 5-12-year-old children were enrolled in the study, who had an ASA physical status I or II and were scheduled for elective penile repair or hypospadias repair.

Exclusion criteria

Exclusion criteria: a known allergy or hypersensitive reaction to DEX or sevoflurane, recent use of drugs that affect the circulatory system or block the sympathetic response, contraindications of laryngeal mask use and sacral anesthesia, developmental delay, psychological diagnosis requiring active treatment, or congenital or neurological diseases.

Design outcomes

Primary

MeasureTime frame
BIS;Narcotrend index;

Secondary

MeasureTime frame
ETsevo;Heart rate;blood pressure;Incidence of intraoperative awareness;Incidence of postoperative adverse events;

Countries

China

Contacts

Public ContactZhen Du

Hunan Children's Hospital

meggyzhen@163.com+86 13574114910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026